These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 14563516)
41. Towards Developing a Scoring System for Febrile Thrombocytopenia. Kshirsagar P; Chauhan S; Samel D J Assoc Physicians India; 2016 Feb; 64(2):14-18. PubMed ID: 27730775 [TBL] [Abstract][Full Text] [Related]
42. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit. Vamvakas EC; Hitzler WE Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342 [TBL] [Abstract][Full Text] [Related]
43. A consistent approach to platelet transfusion in the NICU. Del Vecchio A; Motta M; Radicioni M; Christensen RD J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779 [TBL] [Abstract][Full Text] [Related]
44. Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura. Chandra J; Ravi R; Singh V; Narayan S; Sharma S; Dutta AK Hematology; 2006 Apr; 11(2):131-3. PubMed ID: 16753855 [TBL] [Abstract][Full Text] [Related]
52. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients. Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693 [TBL] [Abstract][Full Text] [Related]
53. The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications? Roberts WE; Perry KG; Woods JB; Files JC; Blake PG; Martin JN Am J Obstet Gynecol; 1994 Sep; 171(3):799-804. PubMed ID: 8092232 [TBL] [Abstract][Full Text] [Related]
54. Clinical practice of platelet transfusions in haemato-oncology. Kreuger AL; Middelburg RA; Zwaginga JJ; van der Bom JG; Kerkhoffs JL Vox Sang; 2015 Jul; 109(1):91-4. PubMed ID: 25833739 [TBL] [Abstract][Full Text] [Related]
55. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag. Tarantino MD; Fogarty PF; Shah P; Brainsky A Platelets; 2015; 26(1):93-6. PubMed ID: 24433306 [TBL] [Abstract][Full Text] [Related]
56. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients. Vinholt PJ; Hvas AM; Nybo M Eur J Haematol; 2014; 92(5):367-76. PubMed ID: 24400878 [TBL] [Abstract][Full Text] [Related]
57. Thrombocytopenia and platelet transfusions in patients with cancer. Valent J; Schiffer CA Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961 [TBL] [Abstract][Full Text] [Related]
59. Platelet transfusion goals in oncology patients. Fasano RM; Josephson CD Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759 [TBL] [Abstract][Full Text] [Related]
60. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy. Callow CR; Swindell R; Randall W; Chopra R Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]